Parkinson's disease is characterized by a progressive loss of dopaminergic neurons in the substantia nigra zona compacta, and in other sub-cortical nuclei associated with a widespread occurrence of Lewy bodies. The cause of cell death in Parkinson's disease is still poorly understood, but a defect in mitochondrial oxidative phosphorylation and enhanced oxidative and nitrative stresses have been proposed. We have studied control wt (C57B1/6), metallothionein transgenic (MT trans ), metallothionein double gene knock (MT dko ), a-synuclein knock out (a-syn ko ), a-synuclein-metallothionein triple knock out (a-syn-MT tko ), weaver mutant (wv/wv) mice, and Ames dwarf mice to examine the role of peroxynitrite in the etiopathogenesis of Parkinson's disease and aging. Although MT dko mice were genetically susceptible to 1, methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) Parkinsonism, they did not exhibit any overt clinical symptoms of neurodegeneration and gross neuropathological changes as observed in wv/wv mice. Progressive neurodegenerative changes were associated with typical Parkinsonism in wv/wv mice. Neurodegenerative changes in wv/wv mice were observed primarily in the striatum, hippocampus and cerebellum. Various hallmarks of apoptosis including caspase-3, TNFa, NFjB, metallothioneins (MT-1, 2) and complex-1 nitration were increased; whereas glutathione, complex-1, ATP, and Ser(40)-phosphorylation of tyrosine hydroxylase, and striatal 18 F-DOPA uptake were reduced in wv/wv mice as compared to other experimental genotypes. Striatal neurons of wv/wv mice exhibited age-dependent increase in dense cored intra-neuronal inclusions, cellular aggregation, proto-oncogenes (c-fos, c-jun, caspase-3, and GAPDH) induction, internucleosomal DNA fragmentation, and neuro-apoptosis. MT trans and a-Syn ko mice were genetically resistant to MPTP-Parkinsonism and Ames dwarf mice possessed significantly higher concentrations of striatal coenzyme Q 10 and metallothioneins (MT 1, 2) and lived almost 2.5 times longer as compared to control wt mice. A potent peroxynitrite ion generator, 3-morpholinosydnonimine (SIN-1)-induced apoptosis was significantly attenuated in MT trans fetal stem cells. These data are interpreted to suggest that peroxynitrite ions are involved in the etiopathogenesis of Parkinson's disease, and metallothionein-mediated coenzyme Q 10 synthesis may provide neuroprotection. fluoro-l-dihydroxy phenylalanine; GIRK channel, G-protein-activated inward-rectifying K + channel; wv/ + , heterozygous weaver mutant mice; wv/wv, homozygous weaver mutant mice; MT dko mice, metallothionein double gene knockout mice; MT trans mice, metallothionein transgenic mice; PD, Parkinson's disease; PCR, polymerase chain reaction; SNpc, substantia nigra pars compacta; a-Syn, a-synuclein; a-Syn ko mice, a-synuclein knockout mice; a-Syn ko -MT tko mice, a-synuclein-metallothionein triple knockout mice;
Introduction
Zinc-containing neurons in the brain are a subclass of glutamatergic neurons, which are found predominantly in the telencephalon. These neurons store zinc in their presynaptic terminals and release it by a calcium-dependent mechanism. These bvesicularQ pools of zinc are viewed as endogenous modulators of ligand-gated and voltage-gated ion channels.
The term metallothionein (MTs) refers to a lowmolecular-weight metal-binding protein (M r =6000-7000) that has unusual biochemical characteristics, such as a high content of cysteine (25-30%), large proportions of serine and lysine (12-18%) , and complete absence of histidine and aromatic amino acids such as tyrosine and phenylalanine. The precise functions of metallothioneins, which may vary in different tissues and organisms, have not been established. However, evidence indicates that the hepatic and renal metallothioneins are involved primarily in metal detoxification [15] , whereas the brain metallothionein isoforms I-III participate in the homeostasis of essential trace metals, such as zinc, and in scavenging free radicals caused by oxidative stress. In addition to scavenging free radicals, metallothionein isoforms exert their neuroprotective effects, in part, by enhancing the concentration of ubiquinol from ubiquinone [11, [13] [14] [15] .
A mutation, by definition, is a change in gene sequence and may be associated with a specific human disease. Genetically engineered mice are produced by induced mutations, including mice with transgenes, mice with targeted mutations (bknockoutsQ), and mice with retroviral or chemically induced mutations. Transgenic mice possess a segment of foreign DNA that is inserted in the host cell genome via pronuclear microinjection (non-homologous recombination), via infection with a retroviral vector, or in some situations via homologous recombination. Gene knockout mice are prepared by first introducing gene disruptions, replacements, or duplications into embryonic stem (ES) cells by homologous recombination. Genetically modified ES cells are microinjected in the host embryos at the eight-cell blastocyst stage. The embryos are then introduced in the pseudo-pregnant females that bear chimeric progeny. The chimeric progeny that carry the knockout gene in their germ line are subsequently bred to establish the gene knockout mice. Chemically induced mutations are produced by mutagens, such as ethyl-nitrosourea (ENU), which induces point mutations. ENU mutation is induced by treating male mice with ENU, and then breeding is performed with untreated females. The progeny are screened for phenotypes of interest carrying point mutations by polymerase chain reaction (PCR) analysis of tail DNA. Detailed information and research applications for different genetically engineered mice are now available on the JAXR Mice Database.
Various experimental models have been proposed to explore basic molecular mechanisms of neurodegeneration in Parkinson's disease (PD) [2, 8, 18] ; however, an appropriate animal model of PD remains unavailable. Like any other experimental model, genetically engineered animals have limitations. On occasions, they do not breed well, or their growth potential may be impaired due to a compromised immune system. Irrespective of these limitations, genetically engineered animals have provided unique opportunities to understand the disease process and novel therapeutic strategies for neurodegenerative disorders. Genetically manipulated mice have been and are being used to investigate amyotrophic lateral sclerosis [1, 6] , Alzheimer's disease [7] , motor neuron disease [5, 19] , Prion diseases [20, 24, 25] , catecholaminergic regulatory systems [3] , and Huntington's disease [22, 26, 27 ].
We have prepared seven different types of genetically engineered mouse models in our laboratories with the primary objectives of exploring the molecular basis of Parkinson's' disease and understanding and preventing neurodegenerative disorders of aging. All the experimental genotypes used in the study were genotyped by tail DNA-PCR analysis. They included control wt (C57Bl/6J) mice, metallothionein double gene knockout (MT dko ) mice (129S7/ SvEvBrd-Mt1 tm1Bri Mt2 tm1Bri/J ; JAX, stock no. 002211), metallothionein transgenic (MT trans ) mice (Tg(Mt1)174Bri/J; stock no. 002209), a-synuclein knockout mice (a-Syn ko ) mice, a-synuclein-metallothionein triple knockout mice (a-Syn-MT tko ), homozygous weaver mutant mice (wv/wv) ( B6CBACaAw-J/A-Kcnj6 wv ), and Ames dwarf ( p/p Prop1 df/J ; stock no. 001618) mice. Our studies have shown that metallothionein transgenic (MT trans ) and a-Syn ko mice are highly suitable to explore basic molecular mechanisms of neuroprotection in PD and aging, whereas MT dko and homozygous weaver mutant (wv/wv) mice can be utilized to understand the basic molecular mechanism of progressive dopaminergic neurodegeneration in PD [16] . Furthermore, Ames dwarf mice can be used to explore specifically the molecular mechanisms of aging and longevity [4] . This review forms a brief report from our laboratories dealing with in vivo and in vitro gene manipulation in order to better understand the basic molecular mechanism(s) of dopaminergic neurodegeneration and to establish the neuroprotective potential of metallothionein isoforms I-III [14, 15] in PD and aging.
Metallothionein gene-manipulated mice
In view of the above, we have studied the effects of various neurotoxins causing parkinsonism in some of these genotypes. Our studies have indicated that MT trans mice are genetically resistant to MPTP, 6-OHDA, salsolinol, and rotenone-induced parkinsonism as compared to MT dko mice, which exhibited an enhanced genetic susceptibility to these agents [10] . In order to understand the basic molecular mechanism of genetic susceptibility of MT dko and resistance of MT trans mice, we exposed these mice to chronic low-dose MPTP. Chronic MPTP (30 mg/kg, i.p., for 7 days) induced severe parkinsonism in MT dko mice, whereas MT trans mice remained resistant to MPTP-induced parkinsonism. Striatal coenzyme Q 10 levels were also significantly reduced in MT dko mice as compared to control wt , MT trans , and a-Syn mice. As such, MT dko mice did not exhibit overt clinical symptoms of neurodegeneration as observed in wv/wv mice; however, they were genetically suscep- tible to MPTP parkinsonism. Chronic treatment with MPTP (30 mg/kg, i.p.) for 7 days induced complete immobilization in MT dko mice, whereas MT trans mice could still walk with their stiff neck and tail. MT dko mice had significantly reduced skin, body, and SN melanin as compared to MT trans mice [31, 33] . There was no significant difference in the litter size among different experimental genotypes, except a-Syn-MT tko mice (six to eight), which had significantly reduced lifespan. Even cultured fetal stem cells derived from MT trans mice embryos were resistant to MPP + -and salsolinol-induced apoptosis, and were genetically resistant to bacterial and fungal infection. MT trans fetal stem cells survived 75F5 days in culture as compared to 55F6 days from the MT dko group ( pb0.01) [28] .
A-Syn-MT tko mice
In order to further explore the basic molecular mechanisms of a-Syn and MTs in the etiopathogenesis of PD, we cross-bred a-Syn males with MT dko female mice and obtained a rare colony of a-Syn-MT tko mice. We examined the effect of chronic rotenone in these genotypes. Our studies have shown that rotenone (1-200 nM) enhanced NFnh expression and inhibited complex-1 expression in a-Syn-MT tko mice [9, 29] . Although the litter size, body size, and lifespans of a-Syn-MT tko mice were significantly reduced as compared to control wt mice, they provided useful information regarding PD and aging. Indeed, lethargic behavior, reduced body size, and reduced lifespan of a-Syn-MT tko mice were associated with significantly reduced complex-1 activity and mitochondrial coenzyme Q 10 levels [31] .
MTs inhibit salsolinol-and 1-benzyl-tetrahydroisoquinoline induced neurotoxicity
Salsolinol and 1-benzyl-tetrahydroisoquinoline (1-Bn-TIQ) induced a-Syn expression, and apoptosis was suppressed upon MT-1 gene overexpression [28] . MT trans fetal stem cells were genetically resistant to peroxynitrite iongenerating compound, 3-morpholinosydnonimine (SIN-1)-induced dopamine oxidation product dihydroxyl phenyl acetaldehyde (DOPAL), and homovalinic acid (HVA)-induced apoptosis.
We have also discovered MT-3 transcripts in human neuroblastoma (SK-N-SH and SH-SY-5Y) cells. MT-3 overexpression in these cells also significantly suppressed MPP + -and salsolinol-induced apoptosis. Direct exposure of SK-N-SH neurons to MPP + induced mitochondrial swelling, aggregation, and apoptosis, represented by phosphatidyl serine externalization, plasma membrane blebbing, and perforation, nuclear DNA fragmentation, and condensation [32] . These apoptotic changes were suppressed by selegiline pretreatment, which we have reported to induce brain regional MTs [28] . Taken together, these observations suggest that brain regional induction of MTs (MTI-III) may provide neuroprotection, whereas substances inhibiting mitochondrial complex-1 activity might be injurious and facilitate parkinsonism in experimental animals as well as in humans. MPTP and rotenone induced a significant depletion of striatal mitochondrial coenzyme Q 10 in MT dko mice; however, coenzyme Q 10 levels remained significantly elevated in MT trans mice even upon chronic exposure to these parkinsonian neurotoxins [28] .
MTs attenuate DOPAL apoptosis
Dopamine oxidation product DOPAL-induced apoptosis in the human dopaminergic (SK-N-SH) cell line was examined in order to validate the observed neuroprotection. Overnight exposure to DOPAL induced apoptosis that was characterized by spherical appearance, plasma membrane perforations, and nuclear DNA condensation as illustrated in Fig. 1 . DOPAL-induced apoptosis was also accentuated in aging mitochondrial genome knockout (RhO mgko ) neurons. Transfection of RhO mgko neurons with MT-1 sense oligonucleotides or with mitochondrial genome encoding complex-1 gene attenuated DOPAL apoptosis, whereas transfection with MT-1 antisense oligonucleotides, accentuated DOPAL apoptosis, indicating the neuroprotective role of MTs in oxidative stress of PD.
MTs inhibit MPP + apoptosis
In order to determine whether MT overexpression provides dopaminergic neuroprotection, we exposed SK-N-SH neurons to MPP + overnight in culture and performed single cell gel electrophoresis. MT-1 sense oligonucloetidetransfected neurons exhibited green comet tails representing mitochondrial damage, whereas MT-1 antisense oligonucleotide-transfected neurons exhibited red comet tails representing nuclear DNA damage, indicating that MT down-regulation may induce severe neurodegeneration in dopaminergic neurons [28] .
SIN-1 enhanced MTs and a-Syn expression
A potent peroxynitrite ion generator, SIN-1, induced MT-1 and a-Syn expression in SK-N-SH neurons in a concentration-dependent manner. SIN-1-induced increases in MT-1 and a-Syn expression were inhibited by either selegiline (10 AM) or coenzyme Q 10 (10 AM) pretreatment, suggesting the neuroprotective role of MTs in peroxynitriteinduced oxidative-and nitrative stresses [28] .
MTs enhance mitochondrial function by augmenting coenzyme Q 10 synthesis
Transfection of cultured dopaminergic (SK-N-SH) neurons with antisense oligonucleotides to MT-1 accentuated-whereas transfection with MT-1 sense oligonucleotides significantly attenuated-MPP + -, 6-OHDA-, rotenone-, and salsolinol-induced apoptosis [28, 30, 32] . These data further suggest a neuroprotective role of metallothionein isoforms I-III in PD.
MTs stabilize mitochondrial genome
Metallothionein stabilization of the mitochondrial genome was confirmed by preparing a cellular model of aging. The cellular model of aging was prepared by selectively knocking out the mitochondrial genome using 5 Ag/l DNA-intercalating agent, ethidium bromide, for 2-3 months in selection medium with appropriate concentrations of glutamine, pyruvate in Dulbecco's modified Eagle's medium (DMEM), 3.7g/l sodium bicarbonate, and 5% fetal bovine serum. A detailed procedure to prepare and identify RhO mgko neurons is described in a recent publication [30] .
Mitochondrial genome knockout neurons are called RhO mgko neurons and have significantly reduced MTs as determined by ELISA [30, 42] . Neuritogenesis involved in neuronal growth and development is significantly reduced in RhO mgko neurons, and they exhibit rounded or elliptical appearance with aggregated mitochondria in the perinuclear region. The nuclear genome remains preserved in RhO mgko neurons; however, the concentration of superoxide dismutase (SOD), glutathione, and adenosine triphosphate (ATP) is significantly reduced as compared to wild-type neurons. We characterized these by reverse transcription polymerase chain reaction (RT-PCR) analysis of ND-1 gene encoding mitochondrial complex-1 (ubiquinone-NADH-oxidoreductase). Transfection of RhO mgko neurons with MT1 sense enhanced-where as transfection with MT1 antisense inhibited-neuritogenesis. Transfection of RhO mgko neurons with mitochondrial genome encoding complex-1 also significantly enhanced neuritogenesis [28] . These observations provide in vitro evidence of the neuroprotective role of MTs through rejuvenation of mitochondrial genome in aging neurons.
Homozygous weaver mutant (wv/wv) mice and PD
A single gene point mutation (G156S) in the G-proteincoupled inward-rectifying potassium channel of wv/wv mice [23] induces loss of the external granular layer neurons in the cerebellum [25, 37] and dopaminergic cells in the striatum [17, 28, 40, 43] . As a consequence of progressive dopaminergic degeneration, wv/wv mice exhibit instability of gait, poor limb coordination, and resting and intention tremors [39] , similar to those observed in PD and chronic drug addiction [12, 21] . However, very little is known about how these degenerative changes are triggered in these genotypes. Recently, we have discovered that neurodegeneration in wv/wv mice is associated with inhibition of complex-1 activity and increased levels of the pro-inflammatory cytokine, NFnh [11] . Chronic exposure of rotenone also induced similar changes in a-Syn-MT tko mice and SK-N-SH neurons, suggesting a common molecular mechanism of oxidative stress, induction of pro-inflammatory cytokines, and induction of apoptotic signaling pathways in neurodegeneration [31] .
Recently, we and others have shown that MT trans and aSyn ko mice are genetically resistant to MPTP parkinsonism as compared to wv/wv and MT dko mice [30, 43] . As such, MT dko mice did not exhibit overt clinical symptoms of movement disorders; however, they were highly susceptible to MPTP parkinsonism due to significantly reduced striatal coenzyme Q 10 as compared to MT trans and a-Syn ko mice [28] . Furthermore, we have discovered that endogenously synthesized MPTP-like tetrahydroisoquinolines (TIQs) such as salsolinol and 1-benzyl TIQ-induced aSyn expression and apoptosis in human dopaminergic (SH-SY5Y) neurons can be attenuated by MT gene overexpression [34, 42] . All of these observations encouraged us to propose that since wv/wv mice and MT dko mice are genetically susceptible to MPTP, they could be used to explore neurodegenerative mechanisms, whereas MT trans mice and a-Syn ko mice could be used to explore neuroprotective mechanisms in PD. In view of the above, we raised control wt (C57BL/6J) mice, wv/wv mice, MT dko mice, MT trans mice, Ames dwarf mice, and a-Syn ko mice. We have shown that striatal serine phosphorylation of tyrosine hydroxylase (TH), 18 F-DOPA uptake, complex-1 activity, a-Syn expression, and Mn-SOD is significantly reduced in wv/wv mice as compared to other experimental genotypes. These changes might induce dopaminergic degeneration in wv/wv mice as seen in PD and chronic drug abuse [38] .
We have shown that serine phosphorylation of the ratelimiting enzyme, TH, which is involved in dopamine synthesis, is significantly inhibited in wv/wv mice as compared to control wt , MT dko , MT trans , and a-Syn ko mice. Expressing mitochondrial complex-1, Mn-SOD, and a-Syn are also significantly inhibited in wv/wv mice. These data lend support to previous [21, 41] and recent observations from our laboratory [13] . Significantly increased mitochondrial Mn-SOD in MT dko mice would indicate a compensatory physiological response to gene manipulation. However, physiological compensation of mitochondrial complex-1 and Mn-SOD was also impaired in wv/wv mice. Thus, wv/ wv mice exhibit severe and progressive NS dopaminergic neurodegenerative changes not observed in other experimental genotypes.
Neurodegenerative changes in wv/wv mice
By employing digital fluorescence imaging microscopy, we have demonstrated neurodegenerative changes in the striatal and cerebellar regions of wv/wv mice. The neurodegenerative changes were represented by apoptotic cell death, which was observed primarily in the external granular layer of the cerebellar cortex. Some of the cells from the external granular layer exhibited apoptosis during migration in the internal granular layer, whereas the neurons in the striatal region exhibited aggregated appearance [10, 37] .
12.
18 F-DOPA distribution kinetics and uptake in wv/wv mice Recently, we have studied in vivo distribution kinetics of 18 F-DOPA in wv/wv mice using the high-resolution Concorde microPET imaging system and CTI-RDS-111 cyclotron. We correlated and confirmed microPET findings with conventional neurochemical analysis. The microPET imaging data provided a regression line with a correlation coefficient of 0.89, suggesting that highresolution microPET imaging can be used to determine the brain regional dopaminergic metabolism in vivo. Micro-PET imaging is highly essential because of the cost of the genetically rare animals. Moreover, microPET imaging is noninvasive and facilitates longitudinal analyses of dopaminergic neurodegeneration in vivo as seen in wv/wv mice. We have now discovered that nigrostriatal 18 F-DOPA uptake is significantly reduced in wv/wv mice as compared to control wt mice. 18 F-DOPA was delocalized in the kidneys of wv/wv mice [35] . The observations made from microPET imaging would indicate that chronic l-DOPA therapy in advanced cases of PD may induce nephrotoxicity because of significantly reduced 18 F-DOPA uptake in their brain and its delocalization in the kidneys [35] . 18 F-DOPA uptake was studied to examine the direct effect of the weaver gene point mutation on DOPA decarboxylase activity. Significantly reduced 18 F-DOPA uptake would indicate reduced DOPA decarboxylase in wv/wv mice. In a previous study, we have shown that dopamine synthesis is significantly reduced in wv/wv mice. MPTP-induced striatal release was significantly high in MT trans mice as compared to wv/wv, MT dko , and aSyn ko mice. Interestingly, striatal release of the dopamine oxidation product DOPAL and HVA was also significantly ( pb0.01) increased in wv/wv mice. These neurochemical changes are reflected as progressive neurobehavioral abnormalities in wv/wv mice [13] .
Abnormal function of A-Syn in wv/wv mice
We have also demonstrated that SDS-soluble a-Syn is significantly reduced in wv/wv mice, which renders them highly susceptible to dopaminergic neurodegeneration and hence parkinsonism. By using digital immunofluorescence imaging, we discovered a-Syn aggregates in the degenerating striatal dopaminergic neurons of wv/wv mice [13] . However, the basic molecular mechanisms of a-Syn aggregation and progressive loss of dopaminergic neurotransmission in wv/wv remain enigmatic. It seems that SDSsoluble a-Syn might have some unknown regulatory role in dopaminergic neurotransmission, whereas SDS-insoluble and aggregated a-Syn might be responsible for neurodegeneration, which remains to be established.
In a recent study, we have reported that the distribution kinetic of 18 F-DOPA is impaired in wv/wv mice by using high-resolution microPET imaging [32] . 18 F-DOPA uptake was significantly reduced in the central nervous system (CNS) and was relocalized in the kidneys of wv/wv mice. These observations further confirmed impaired CNS dopaminergic neurotransmission in wv/wv mice. Dopaminergic neurons and their projection systems are important in some fundamental human activities like locomotion, feeding, and reproduction; essential for survival and procreation; and are relevant to pathologies like PD and drug addiction [13] . Mutant animals with defects specific to one or more projection systems might be useful for studying the role of individual dopaminergic projection systems [21] . Since wv/ wv mice exhibit age-dependent nigrostriatal dopaminergic neurodegeneration as observed in PD even without any exogenous neurotoxic insult, they may be used to explore the basic molecular mechanism of progressive neurodegeneration in PD.
Although MT gene ablation renders MT dko mice highly susceptible to PD, progressive neurodegeneration as observed in wv/wv mice was not observed in these animals [31] . However, significantly reduced serine(40)-phosphorylated TH immunoreactivity particularly in the wv/wv mice striatum suggests that the nigrostriatal dopaminergic system is highly susceptible to the weaver gene point mutation as compared to other gene manipulations. For example, Mn-SOD expression was significantly increased in MT dko mice but remained unchanged in MT trans and a-Syn ko mice, indicating the neuroprotective role of MTs. Significantly reduced Mn-SOD expression would suggest impaired mitochondrial bioenergetics in wv/wv mice, and significantly high Mn-SOD in MT dko mice would suggest physiological compensation in response to MT gene ablation. Furthermore, reduced complex-1 expression would also indicate impaired mitochondria bioenergetics in wv/wv and MT dko mice. Previous studies have also reported mitochondrial damage during CNS development in wv/wv mice [43] . We have shown that MPP + -induced DNA fragmentation was exaggerated in aging RhO mgko , MT dko , and caspase-3-transfected dopaminergic (SK-N-SH) neurons, and was significantly reduced in MT-overexpressing neurons [28] . MPP + -induced degenerative changes were attenuated in MT trans , MT-1, and mitochondrial genome-transfected neurons, indicating the neuroprotective role of MTs [29] .
It has been reported that the density of striatal dopaminergic nerve terminals was increased following riluzole administration in wv/wv mice, suggesting its protective role in dopaminergic neurons [9] . Transplantation of E12 mesencephalic cells into the striatal region of DA-deficient wv/wv mice improved glutamatergic corticostriatal and dopaminergic nigrostriatal pathways as estimated by 3 H-CNQX and 3 Hglutamate binding studies [21] . Dopamine D2 receptor-like immunoreactivity was significantly reduced in the substantia nigra pars compacta (SNpc) of wv/wv mice and the synaptic number was also reduced. Degenerative changes were observed in some of the D2 receptor-like immunoreactive profiles, suggesting that the synaptic integrity of the dopaminergic system in the striatum is compromised in wv/ wv mice, which in turn affects the functional efficacy of the basal ganglia circuitry. Thus, the altered nigrostriatal dopaminergic neurocircuitry is expressed as Parkinson-like symptoms in these genotypes [41] . In addition to significantly reduced TH, a-Syn, 18 F-DOPA uptake, and complex-1, wv/ wv mice exhibit significantly reduced dopamine, ATP, coenzyme Q 10 , and progressive neurodegeneration in the hippocampal dentate gyrus and cerebellar cortex [13] . These multiple neurodegenerative changes occur concomitantly with neurobehavioral abnormalities, morbidity, and eventually mortality in wv/wv mice [13] .
MT trans striatal fetal stem cell transplantation
In an in vitro analysis, we confirmed that MT trans striatal fetal stem cells are genetically resistant to the dopamine oxidation product DOPAL and to 1-methyl-4-phenyl pyridinium ion (MPP + )-induced apoptosis [30] . Since MT trans striatal fetal stem cells are genetically resistant to environmental and parkinsonian neurotoxins, and wv/wv mice exhibit progressive dopaminergic neurodegeneration in the NS system during aging, we have now proposed to explore the structural and functional integrity of MT trans and Ames dwarf mouse fetal stem cells grafts in wv/wv mice by employing 18 F-DOPA and 18 F-rotenone microPET neuroimaging. These studies will provide more precise information regarding the success rate of fetal stem cell transplantation and other unexplored yet important issues on graft rejection and acceptance in PD.
We have shown that a-Syn ko mice were highly resistant, whereas MT dko mice and weaver mutant mice were highly susceptible to chronic MPTP and rotenone-induced a-Syn nitration, complex-1 inhibition, and NFnh activation [11] . MT dko mice did not exhibit obvious clinical symptoms of neurodegeneration; however, mitochondrial Mn-SOD was significantly induced in these genotypes as a physiological adaptation to MT gene ablation. Progressive and severe NS dopaminergic neurodegenerations associated with typical parkinsonism (neck muscle rigidity, body tremors, walking difficulties, and postural irregularities) were observed in adult wv/wv mice. Furthermore, wv/wv mice exhibited significant reduction in serine phosphorylation of TH, reduced 18 F-DOPA uptake, and a-Syn expression [13] .
Neuroprotective role of TRPC1 in PD
Mammalian homologues of the Drosophila canonical transient receptor potential (TRP) protein have been implicated to function as Ca 2+ channels [36] . In a recent study, we have explored the molecular mechanism of neuroprotection by TRPC1 in human dopaminergic (SH-SY-5Y) cells. TRPC1 expression was significantly inhibited by exposing the human dopaminergic (SH-SY-5Y) cells to MPP + or salsolinol. Overexpression of TRPC1 in SH-SY-5Y neurons provided protection against these parkinsonian neurotoxins and inhibited the translocation of protein needed for apoptosis as confirmed by immunoblotting and confocal microscopy [44] .
Increased lifespan of Ames dwarf mice
We have discovered that Ames dwarf mice survived 2.5 longer than control wt mice [4] . Studies conducted on long-living Ames mice have shown that these mice express higher levels of metallothionein isoforms and antioxidant enzymes, produce fewer free radicals, and exhibit less DNA and protein oxidative damage when compared to age-matched wild-type mice [45] [46] [47] [48] . In addition, dwarf mice outsurvive control wt mice when challenged in vivo with the systemic oxidative stressor, paraquat. Importantly, we have shown that metallothionein levels are significantly higher in dwarf tissues compared to wild-type tissues [4] . These observations, along with those in lower species, indicate that reduced growth hormone signaling enhances antioxidant expression and extends lifespan.
Conclusions
Pharmacological interventions involving brain regional induction of MTs, TRPC1, and regulating growth hormone expression might be helpful in the clinical management of PD and other neurodegenerative disorders of unknown etiopathogenesis. Brain regional induction of MTs, in addition to metal detoxification, helps in reactive oxygen species scavenging, coenzyme Q 10 synthesis, complex-1 activation, attenuation of a-Syn nitration, and suppression of pro-inflammatory cytokines TNF a and NF nh involved in the etiopathogenesis of PD and aging. These data indicate that brain regional induction of MTs might be helpful in the prevention of PD in aging brain; whereas MT trans mice and Ames dwarf mice could be further explored to understand the success rate of fetal stem cell transplantation in PD and other diseases such as AD.
Based on the present study, it is suggested that wv/wv mice and MT dko mice could be used to investigate the basic molecular mechanism of neurodegeneration, whereas MT trans mice, Ames dwarf mice, and a-Syn ko mice could be used to explore the basic molecular mechanism of neuroprotection in PD and movement disorders and neurological impairments associated with chronic cocaine, MPTP, or amphetamine addiction. Further studies in this direction are in progress. Furthermore, Ames dwarf mouse model would provide more leads in the basic understanding of aging, oxidative stress, and longevity.
